Tactile Systems Technology (TCMD) Aktie Kurs

Tactile Systems Technology Kurs

NASDAQ·LUKKET
25,60
​
Markedet lukket

Omsætningen er vokset med 19,9 % om året de seneste 12 år til 329,52 Mio. USD. Indtjening pr. aktie er vokset med 16,2 % om året de seneste 12 år. Tactile Systems Technologys nettoavance ligger på 5,8 %, op fra -5,7 % for flere år siden. Analytikernes mediankursmål er 40,00 USD, hvilket er over den aktuelle kurs med 56,2 %. Af 10 analytikere anbefaler 9 køb — den samlede vurdering er Køb.

Tactile Systems Technology aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Tactile Systems Technology aktie og aktieanalyse

Tactile Systems Technology Inc. er et amerikansk medicinteknologisk selskab, der producerer innovative terapiudstyr til behandling af perifer arteriel sygdom (PAD) og lymfesygdomme. Selskabet blev grundlagt i 1995 af Gerald R. Mattys og har hovedkontor i Minneapolis, Minnesota.

Hyppigt stillede spørgsmål om Tactile Systems Technology-aktien

Tactile Systems Technology Inc is a medical technology company specializing in the development and commercialization of innovative medical devices to treat chronic diseases. Their business model focuses on providing cost-effective and patient-centered solutions for the management of lymphedema and other vascular conditions. By offering advanced and wearable compression therapy products, Tactile Systems aims to improve patients' quality of life and medical outcomes. With a strong emphasis on research and development, they continuously strive to enhance their product portfolio and expand their market reach. Tactile Systems' commitment to innovative healthcare solutions positions them as a leading player in the medical technology industry.

Tactile Systems Technology Inc is primarily active in the healthcare industry.

The main competitors of Tactile Systems Technology Inc in the market include companies such as Medtronic, Smith & Nephew, Hill-Rom Holdings, and Acelity.

Tactile Systems Technology Inc, commonly known as Tactile Medical, is a leading medical technology company based in Minneapolis, Minnesota. Founded in 1995, the company specializes in developing and providing at-home therapy devices and solutions for the treatment of lymphedema and chronic venous insufficiency. Tactile Medical's mission is to advance patient care by addressing unmet medical needs through innovative products and services. With its cutting-edge technology and dedication to improving patients' quality of life, Tactile Medical has become a trusted name in the medical community. Despite its relatively young age, the company has achieved significant growth and recognition, making it a promising investment option for those interested in the medical technology sector.

Tactile Systems Technology Inc has achieved several significant milestones. One notable accomplishment is its successful initial public offering in July 2016, which enabled the company to raise funds for future growth and expansion. Additionally, Tactile Systems has developed and launched innovative medical devices, including its Flexitouch system for lymphedema management. The company has received multiple awards and recognition for its contributions to the healthcare industry, such as being named to the Forbes 2017 list of America's Best Small Companies. Tactile Systems Technology Inc continues to focus on advancing patient care through its advanced medical solutions and dedication to innovation.

Tactile Systems Technology Inc is primarily present in the United States.

Tactile Systems Technology Inc is a leading medical technology company that specializes in developing and providing at-home therapy solutions. Their core values include patient-centricity, innovation, integrity, and collaboration. With a focus on improving the lives of patients with chronic diseases, Tactile Systems Technology Inc is dedicated to developing high-quality products that offer comfort and convenience. The company's corporate philosophy revolves around delivering effective and personalized healthcare solutions through a comprehensive understanding of patient needs. Tactile Systems Technology Inc consistently prioritizes patient well-being and strives to enhance their quality of life through continuous advancements in medical technology and patient care.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 40,00 USD for Tactile Systems Technology-aktien (median: 40,00 USD), svarende til +56,2 % i forhold til seneste kurs. Konsensus bygger på 10 analytikervurderinger.

10 analytikere vurderer i øjeblikket Tactile Systems Technology-aktien: 9 anbefaler køb, 1 hold og 0 salg. For 2026 forventer analytikere, at Tactile Systems Technology genererer omsætning på 362,52 Mio. USD og indtjening pr. aktie på 1,10 USD.

Omregnet til den aktuelle valutakurs handles Tactile Systems Technology-aktien til 23,33 EUR (25,60 USD).

Tactile Systems Technology-aktien (TCMD) er noteret på 3 børser, herunder: NASDAQ (TCMD), Frankfurt (3L3.F), München (3L3.MU).

The company Tactile Systems Technology Inc is a US-American company based in Minneapolis that specializes in the development and distribution of medical devices for the treatment of peripheral circulation disorders. The company's business model is based on a wide range of non-invasive therapy devices that are used by patients to treat circulation disorders in the lower extremities. The Tactile product portfolio includes a range of devices, from light compression stockings to advanced systems with more comprehensive functions and applications. Tactile devices have been designed to improve circulation and support the healing of chronic wounds or injuries caused by poor circulation. The therapy devices are based on a patented technological approach - a unique pneumatic system that applies pulsating pressure to the lower extremities to improve circulation and reduce edema. The devices are designed to meet a variety of patient needs and can be used both in a clinical setting and at home. In addition to its therapy devices, Tactile also offers a range of services to support patients in the effective use of the devices and improve outcomes. These include patient and medical professional training programs, support services, and data analysis tools to ensure optimal therapy. The market for peripheral circulation disorders and chronic wounds is large and growing. According to estimates from the American Heart Association, more than 8.5 million people in the United States alone suffer from circulation disorders in the lower extremities, and this number is expected to continue rising due to factors such as increasing age and lifestyle diseases like diabetes. Tactile has managed to establish itself as a market leader in this segment by providing innovative products and services tailored to the needs of patients and medical professionals. The company has built a strong brand and made its products popular among doctors and clinics in the US. It also has a strong presence in the international market and has successfully expanded into new regions. Overall, Tactile offers its customers an integrated system of therapy devices and services aimed at improving the treatment of circulation disorders and maximizing patient outcomes. With its proven business model, strong brand presence, and commitment to product innovation and quality, Tactile is well positioned to continue growing successfully and increase its market share.

forventet-omsætningen for Tactile Systems Technology er 362,52 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for Tactile Systems Technology er 25,24 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Tactile Systems Technology er i øjeblikket 23,38. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Tactile Systems Technology-aktien.

Pris-til-salgs-forholdet (P/S) for Tactile Systems Technology er i øjeblikket 1,63. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Tactile Systems Technology-aktien.

AlleAktien-kvalitetsscore for Tactile Systems Technology er 6/10.

ISIN for Tactile Systems Technology er US87357P1003. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Tactile Systems Technology er A2APEV. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Tactile Systems Technology er TCMD. Tickersymbolet bruges til at handle Tactile Systems Technology-aktier på børsen.

Fair værdiTerminal
25,86 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Sundhedsvæsens Udstyr & Forsyninger
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
303.427,26 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Land
Valuta
USD
Børsintroduktion
28. jul. 2016
ISIN
US87357P1003
CUSIP
87357P100
SEDOL
BZB1XF2
Markedsværdi
52-ugers interval
AAQS
6 / 10
PEG-forhold
1,53
P/E-forhold
P/Ee 2026
22,66
P/Ee 2027
17,12
P/Ee 2028
13,03
P/S
P/Se
1,63
EV/EBIT
17,23
K/B-forhold
2,61
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8,13 %
Sidst opdateret 23. nov. 2026, 00.31

Tactile Systems Technology Ticker

FRANKFURT · 3L3.FMÜNCHEN · 3L3.MUNASDAQ · TCMD

Tactile Systems Technology FIGI

TCMD:US · BBG001B12Z39TCMD:UA · BBG00C0BG466TCMD:UC · BBG00C0BG475TCMD:UN · BBG00C0BG493TCMD:UP · BBG00C0BG4B0TCMD:UQ · BBG00C0BG4C9TCMD:UB · BBG00C0BG4D8TCMD:UM · BBG00C0BG4G5TCMD:UX · BBG00C0BG4H4TCMD:UD · BBG00C0BG4N7TCMD:UF · BBG00C0BG4R3TCMD:VY · BBG00C0BG4S2